Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary

Taro Pharmaceutical Industries

27/05/2022 10:25

* Taro Pharmaceutical Industries Ltd  TARO.N  reported
quarterly
adjusted earnings of 73 cents​​ per share for the quarter ended
in March. The lone analyst forecast for the quarter was
for earnings of 88 cents per share.
    * Revenue fell 3.4% to $143.26 million from a year ago; 
analysts
expected $147.01 million. 
    * Taro Pharmaceutical Industries Ltd's reported EPS for the
quarter was 73 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Taro Pharmaceutical Industries Ltd shares had fallen
by 18.6%
this quarter and lost 29.7% so far this year.
    * The company reported quarterly net income of $27.4
million.
    * Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $73.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 27 at 09:24 a.m.  ​All
figures in US dollars unless otherwise stated